ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Oncogenesis
SJR: 0.946 SNIP: 0.503 CiteScore™: 2

ISSN 印刷: 0893-9675
ISSN オンライン: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.v20.i5-6.170
pages 485-508

Emerging Receptor Tyrosine Kinase Drug Targets: Implications for Antibody-Based Therapies for Oncology and Immunologic Disorders

Theresa M. LaVallee
Kolltan Pharmaceuticals, Inc., New Haven, CT
Diego Alvarado
Kolltan Pharmaceuticals, Inc., New Haven, CT
Andrew J. Garton
Kolltan Pharmaceuticals, Inc., New Haven, CT
E. Sergio Trombetta
Kolltan Pharmaceuticals, Inc., New Haven, CT
Richard Gedrich
Kolltan Pharmaceuticals, Inc., New Haven, CT
Gerald McMahon
Kolltan Pharmaceuticals, Inc., New Haven, CT

要約

Protein kinases play a critical regulatory role in essentially every aspect of cell biology. Of the 518 known kinases, the most successful class for drug targeting is the receptor tyrosine kinase (RTK) family consisting of 58 distinct and diverse members. RTKs regulate a broad range of cellular functions, including proliferation, differentiation, survival, and apoptosis and have been intensively studied in development and cancer. Targeting of RTKs has resulted in many marketed small molecule and antibody-based drugs in a number of different solid tumors and hematological malignancies, and more recently in inflammatory diseases such as idiopathic pulmonary fibrosis. In this review, we discuss some of the RTKs in cancer in which drugs targeting the ErbB family (EGFR, HER2, and ErbB3) and KIT have had meaningful clinical benefit to cancer patients, RTKs' emerging role in regulating innate immunity, and the potential to explore targeting RTKs outside of oncology.


Articles with similar content:

Immune Cell Functions in Pancreatic Cancer
Critical Reviews™ in Immunology, Vol.20, 2000, issue 5
Jules E. Harris, Janet M. D. Plate
Epidermal Growth Factor Receptor Tyrosine Kinase: A Potential Target in Treatment of Non-Small-Cell Lung Carcinoma
Journal of Environmental Pathology, Toxicology and Oncology, Vol.36, 2017, issue 2
Niranjali Devaraj, Venugopal Vinod Prabhu
Therapeutic Targeting of the Epidermal Growth Factor Receptor in Human Cancer
Critical Reviews™ in Oncogenesis, Vol.17, 2012, issue 1
Nathalie S. Dhomen, Niall Tebbutt, John Mariadason, Andrew M. Scott
Highlights of the Fifth International Workshop on Nitric Oxide and Cancer
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 5-6
Claudia Ferroni, Greta Varchi, Valentina Rapozzi
Ligand-Receptor-Mediated Drug Delivery: An Emerging Paradigm in Cellular Drug Targeting
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.18, 2001, issue 1
Suresh P. Vyas, V. Sihorkar, Amarjit Singh